These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 25865968)

  • 1. The narrow road to the indigenous rotavirus vaccine.
    Das BK
    Indian J Med Microbiol; 2015; 33(2):203-4. PubMed ID: 25865968
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduction in rotavirus disease due to the infant immunisation programme in England; evidence from national surveillance.
    Atchison C; Collins S; Brown D; Ramsay ME; Ladhani S;
    J Infect; 2015 Jul; 71(1):128-31. PubMed ID: 25614960
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of rotavirus disease burden and vaccine effectiveness in India.
    Kang G; Tate JE; Parashar UD
    Vaccine; 2015 Dec; 33(51):7143. PubMed ID: 26675194
    [No Abstract]   [Full Text] [Related]  

  • 4. Rotavirus vaccines: successes and challenges.
    Glass RI; Parashar U; Patel M; Gentsch J; Jiang B
    J Infect; 2014 Jan; 68 Suppl 1():S9-18. PubMed ID: 24156947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An age-structured epidemic model of rotavirus with vaccination.
    Shim E; Feng Z; Martcheva M; Castillo-Chavez C
    J Math Biol; 2006 Oct; 53(4):719-46. PubMed ID: 16915388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rotavirus vaccines at the threshold of implementation in India.
    Tate JE; Arora R; Kang G; Parashar UD
    Natl Med J India; 2014; 27(5):245-8. PubMed ID: 26037421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histo-blood group antigens as receptors for rotavirus, new understanding on rotavirus epidemiology and vaccine strategy.
    Jiang X; Liu Y; Tan M
    Emerg Microbes Infect; 2017 Apr; 6(4):e22. PubMed ID: 28400594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rotarix: a rotavirus vaccine for the world.
    Ward RL; Bernstein DI
    Clin Infect Dis; 2009 Jan; 48(2):222-8. PubMed ID: 19072246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case-control evaluation of the effectiveness of the G1P[8] human rotavirus vaccine during an outbreak of rotavirus G2P[4] infection in central Australia.
    Snelling TL; Andrews RM; Kirkwood CD; Culvenor S; Carapetis JR
    Clin Infect Dis; 2011 Jan; 52(2):191-9. PubMed ID: 21288843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of rotavirus vaccination: the importance of monitoring strains.
    Gentsch JR; Parashar UD; Glass RI
    Future Microbiol; 2009 Dec; 4(10):1231-4. PubMed ID: 19995181
    [No Abstract]   [Full Text] [Related]  

  • 11. Rotavirus vaccine introduction in Mexico sets precedent.
    Braine T
    Bull World Health Organ; 2005 Mar; 83(3):167. PubMed ID: 15798837
    [No Abstract]   [Full Text] [Related]  

  • 12. Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belém, Brazil.
    Justino MC; Linhares AC; Lanzieri TM; Miranda Y; Mascarenhas JD; Abreu E; Guerra SF; Oliveira AS; da Silva VB; Sanchez N; Meyer N; Shafi F; Ortega-Barria E; Soriano-Gabarró M; Colindres RE
    Pediatr Infect Dis J; 2011 May; 30(5):396-401. PubMed ID: 21150692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained efficacy of the pentavalent rotavirus vaccine, RV5, up to 3.1 years following the last dose of vaccine.
    Vesikari T; Karvonen A; Ferrante SA; Kuter BJ; Ciarlet M
    Pediatr Infect Dis J; 2010 Oct; 29(10):957-63. PubMed ID: 20442684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bovine rotavirus pentavalent vaccine development in India.
    Zade JK; Kulkarni PS; Desai SA; Sabale RN; Naik SP; Dhere RM
    Vaccine; 2014 Aug; 32 Suppl 1():A124-8. PubMed ID: 25091665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine.
    Nakagomi T; Cuevas LE; Gurgel RG; Elrokhsi SH; Belkhir YA; Abugalia M; Dove W; Montenegro FM; Correia JB; Nakagomi O; Cunliffe NA; Hart CA
    Arch Virol; 2008; 153(3):591-3. PubMed ID: 18175037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rotavirus vaccines in Belgium: policy and impact.
    Braeckman T; Van Herck K; Raes M; Vergison A; Sabbe M; Van Damme P
    Pediatr Infect Dis J; 2011 Jan; 30(1 Suppl):S21-4. PubMed ID: 21183836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Handling uncertainty in dynamic transmission models.
    Pitman R; Carroll S
    Vaccine; 2011 May; 29(22):3827; author reply 3828. PubMed ID: 20888874
    [No Abstract]   [Full Text] [Related]  

  • 18. The rotavirus saga revisited.
    Shaw AR
    Annu Rev Med; 2013; 64():165-74. PubMed ID: 23121179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reaching MDG 4 in India: a role for rotavirus vaccine?
    Nelson EA; Walker DG
    Clin Infect Dis; 2011 Jan; 52(2):178-9. PubMed ID: 21288840
    [No Abstract]   [Full Text] [Related]  

  • 20. Intussusception and rotavirus vaccines: consensus on benefits outweighing recognized risk.
    Buttery JP; Standish J; Bines JE
    Pediatr Infect Dis J; 2014 Jul; 33(7):772-3. PubMed ID: 24732449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.